These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 2745656)

  • 1. Comparison of the GC/MS ion trapping technique with GC-FTIR for the identification of stimulants in drug testing.
    de Jong EG; Keizers S; Maes RA
    J Anal Toxicol; 1990; 14(2):127-31. PubMed ID: 2325379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of illegally distributed anabolic steroid products by liquid chromatography with identity confirmation by mass spectrometry or infrared spectrophotometry.
    Walters MJ; Ayers RJ; Brown DJ
    J Assoc Off Anal Chem; 1990; 73(6):904-26. PubMed ID: 2289923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatography-mass spectrometry-Fourier transform infrared spectrometry and high-performance liquid chromatographic characterization of mononitro- and dinitro-isomers from the nitration of N,N-dimethyldiphenylacetamide.
    Soják L; Perjéssy A; Kubinec R; Cambáliková J; Giumanini AG; Verardo G; Magnan MM
    J Chromatogr A; 2000 May; 878(2):235-47. PubMed ID: 10866069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forensic Drug Identification, Confirmation, and Quantification Using Fully Integrated Gas Chromatography with Fourier Transform Infrared and Mass Spectrometric Detection (GC-FT-IR-MS).
    Lanzarotta A; Lorenz L; Voelker S; Falconer TM; Batson JS
    Appl Spectrosc; 2018 May; 72(5):750-756. PubMed ID: 29154671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an open screening method for doping substances in urine by gas chromatography quadrupole time-of-flight mass spectrometry.
    Polet M; Van Gansbeke W; Van Eenoo P
    Anal Chim Acta; 2018 Dec; 1042():52-59. PubMed ID: 30428988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive confirmation of identity of doping agents using gas chromatography-mass spectrometry with Fourier transform infrared spectrometry.
    Selala MI; Janssens JJ; Coucke V; Andries S; Schepens PJ
    J Chromatogr; 1989 Apr; 489(1):51-6. PubMed ID: 2745656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug detection in hair by chromatographic procedures.
    Moeller MR
    J Chromatogr; 1992 Sep; 580(1-2):125-34. PubMed ID: 1400819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forensic applications of supercritical fluid chromatography - mass spectrometry.
    Pauk V; Lemr K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():184-196. PubMed ID: 29684910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins.
    Thevis M; Schänzer W
    J Chromatogr Sci; 2005 Jan; 43(1):22-31. PubMed ID: 15808003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of interferences for gas chromatography/mass spectrometry analysis of urine for drugs of abuse.
    Wu AH
    Ann Clin Lab Sci; 1995; 25(4):319-29. PubMed ID: 7668815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.